Effective antiretroviral therapy, anal high-risk human papillomavirus, anal intraepithelial neoplasia and anal cancer: a systematic review and meta-analysis

Published: 12 February 2020| Version 1 | DOI: 10.17632/vxbt7rc27j.1
Contributor:
Helen Kelly

Description

This dataset contains data evaluating the association of antiretroviral therapy, HIV plasma viral load and contemporary and nadir CD4+ T-cell count (exposures) and the following outcomes: outcomes: anal HR-HPV prevalence, incidence and persistence; cytology- or histology-confirmed anal squamous intraepithelial lesions [SIL]/anal intraepithelial neoplasia [AIN] prevalence, incidence, progression or regression, and anal cancer incidence among people living with HIV (PLHIV). It includes raw data for outcomes and exposure, and the crude effect estimate, and the adjusted effect estimate provided in the published material, in additional to information on the any adjustment for confounding, where available.

Files

Institutions

London School of Hygiene and Tropical Medicine, Institut Catala d' Oncologia

Categories

Anal Cancer, HIV/AIDS, Human Papillomavirus, Clinical Management in Antiretroviral Therapy

Licence